Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself

Journal of Reproductive Immunology

Volumn 43, Issue 2, 1999, Pages 175-182

  Khalil Daher, Iman ^a   Riteau, Beatrice ^a   Menier, Catherine ^a   Sedlik, Christine ^a   Paul, Pascale ^a   Dausset, Jean ^b   D Carosella, Edgardo ^a   Rouas Freiss, Nathalie ^a  

^a Inst Univ d'Hématologie   (France)

^b Fondation Jean Dausset   (France)

Author keywords

HLA E; HLA G1; K562 HLA G1; Killing inhibitory receptors; NK

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CYTOLYSIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NATURAL KILLER CELL; PRIORITY JOURNAL;

CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL;

EID: 0032799439     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(99)00032-7     Document Type: Article

References (18)

1. Braud V.M., Jones E.V., McMicheal A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequences derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27:1997;1164-1169.
2. Braud V.M., Allan D.S.J., O'Callaghan C.A., Soderstom K., D'Andrea A., Ogga G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMicheal A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
3. Cantoni C., Verdiani S., Falco M., Pessino A., Cilli M., Conte R., Pende D., Ponte M., Mikaelson M.S., Moretta L., Biassoni R. P49 a novel putative HLA-class I-specific inhibitory NK receptor belonging to the Immunoglobulin Superfamily. Eur. J. Immunol. 28:1998;1980-1990.
4. Crisa L., McMaster M.T., Ishii J.F., Fisher S.J., Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class 1b HLA-G molecule with fetal trophoblast. J. Exp. Med. 186:1997;289-298.
5. Colonna M., Samaridis J., Cella M., Angman L., Allen R., O'Callaghan C., Dunbar R., Ogg G., Cerundolo V., Rolink A. A common inhibitory receptors for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Immunol. 160:1998;3096-3100.
6. Diehl M., Munz C., Keilholz W., Stevanovic S., Holmes N., Loke Y.W., Rammensee H.G. Non classical HLA-G molecules are classical peptide presenters. Curr. Biol. 6:1995;305-314.
7. Houlihan J.M., Biro P.A., Harper H.L., Jenkinson H.J., Holmes C.H. The human aminion is a site of HLA class 1b expression: evidence for the expression of HLA-E and HLA-G. J. Immunol. 154:1995;5665-5674.
8. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., Demars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:1990;220-223.
9. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:1998a;5199-5204.
10. Lee N., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:1998b;4951-4960.
11. Munz C., Holmes N., King A., Loke Y.W., Colonna M., Schild H., Rammensee H.-G. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185:1997;385-391.
12. Pazmany L., Mandelboim O., Vales-Gomez M., Davis D.M., Reyburn H.T., Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science. 274:1996;792-795.
13. Perez-Villar J.J., Melero I., Navarro F., Carretero M., Bellon T., Llano M., Colonna M., Geraghty D.E., Lopez-Botet M. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cell expressing HLA-G. J. Immunol. 158:1997;5736-5743.
14. Rouas-Freiss N., Marchal R., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA. 94:1997a;11520-11525.
15. Rouas-Freiss N., Marchal R., Kirszenbaum M., Dausset J., Carosella E.D. The (1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. USA. 94:1997b;5249-5254.
16. Shawar S.M., Vyas J.M., Rodgers J.R., Rich R.R. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:1994;839-880.
17. Ulbrecht M., Honka T., Person S., Johnson J.P., Weiss E.H. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J. Immunol. 149:1992;2945-2953.
18. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:1996;369-396.